|Bid||58.04 x 1300|
|Ask||58.09 x 1400|
|Day's range||57.18 - 58.57|
|52-week range||57.04 - 85.97|
|Beta (5Y monthly)||0.57|
|PE ratio (TTM)||57.75|
|Earnings date||28 Oct 2020|
|Forward dividend & yield||2.72 (4.65%)|
|Ex-dividend date||14 Dec 2020|
|1y target est||74.58|
New daily records for COVID-19 cases and hospitalizations mean these stocks are probably headed in opposite directions.
How far off is Gilead Sciences, Inc. (NASDAQ:GILD) from its intrinsic value? Using the most recent financial data...
These two drugmakers are unlikely to slash or suspend their dividend payments -- even in the midst of a recession.